| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6017365 | Experimental Neurology | 2015 | 10 Pages |
Abstract
By suppressing inflammation and oxidative stress, combined treatment with lenalidomide and nanoceria can reduce demyelination and associated neurological symptoms in EAE mice. Our preclinical data suggest a potential application of this combination therapy in MS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Erez Eitan, Emmette R. Hutchison, Nigel H. Greig, David Tweedie, Hasan Celik, Soumita Ghosh, Kenneth W. Fishbein, Richard G. Spencer, Carl Y. Sasaki, Paritosh Ghosh, Soumen Das, Susheela Chigurapati, James Raymick, Sumit Sarkar, Srinivasulu Chigurupati,